SE0103509D0 - Rosuvastatin in pre demented states - Google Patents
Rosuvastatin in pre demented statesInfo
- Publication number
- SE0103509D0 SE0103509D0 SE0103509A SE0103509A SE0103509D0 SE 0103509 D0 SE0103509 D0 SE 0103509D0 SE 0103509 A SE0103509 A SE 0103509A SE 0103509 A SE0103509 A SE 0103509A SE 0103509 D0 SE0103509 D0 SE 0103509D0
- Authority
- SE
- Sweden
- Prior art keywords
- demented
- rosuvastatin
- states
- dementia
- rosuvastiatin
- Prior art date
Links
- 206010012289 Dementia Diseases 0.000 title abstract 3
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 title 1
- 229960000672 rosuvastatin Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
Priority Applications (19)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0103509A SE0103509D0 (sv) | 2001-10-19 | 2001-10-19 | Rosuvastatin in pre demented states |
| ARP020103895A AR036891A1 (es) | 2001-10-19 | 2002-10-17 | Rosuvastatina en estados predemenciales |
| US10/492,971 US20060229321A1 (en) | 2001-10-19 | 2002-10-18 | Rosuvastatin in pre demented states |
| BR0213434-9A BR0213434A (pt) | 2001-10-19 | 2002-10-18 | Método para evitar demência em um paciente, e, uso de rosuvastatina ou seu sal farmaceuticamente aceitável |
| RU2004112422/14A RU2004112422A (ru) | 2001-10-19 | 2002-10-18 | Роувастатин в преддеменционных состояниях |
| MXPA04003631A MXPA04003631A (es) | 2001-10-19 | 2002-10-18 | Rosuvastatina en estados de pre-demencia. |
| JP2003535798A JP2005505605A (ja) | 2001-10-19 | 2002-10-18 | 前痴呆状態におけるロスバスタチン |
| CNA028253477A CN1604780A (zh) | 2001-10-19 | 2002-10-18 | 在前痴呆状态中使用罗苏伐他汀 |
| PL02369573A PL369573A1 (en) | 2001-10-19 | 2002-10-18 | Rosuvastatin in pre demented states |
| EP02783893A EP1446123A1 (en) | 2001-10-19 | 2002-10-18 | Rosuvastatin in pre demented states |
| PCT/SE2002/001911 WO2003032995A1 (en) | 2001-10-19 | 2002-10-18 | Rosuvastatin in pre demented states |
| CA002463597A CA2463597A1 (en) | 2001-10-19 | 2002-10-18 | Rosuvastatin in pre demented states |
| IL16138002A IL161380A0 (en) | 2001-10-19 | 2002-10-18 | Rosuvastatin in pre demented states |
| HU0401798A HUP0401798A3 (en) | 2001-10-19 | 2002-10-18 | Use of rosuvastatin for preparation of pharmaceutical compositions usable in pre demented states |
| KR10-2004-7005585A KR20040058201A (ko) | 2001-10-19 | 2002-10-18 | 치매전 상태에 사용되는 로수바스타틴 |
| IS7218A IS7218A (is) | 2001-10-19 | 2004-04-13 | Notkun rósúvastatíns á forstigi vitglapa |
| ZA200402844A ZA200402844B (en) | 2001-10-19 | 2004-04-15 | Rosuvastatin in pre demented states. |
| CO04035705A CO5580773A2 (es) | 2001-10-19 | 2004-04-19 | Rosuvastatina en estados pre dementes |
| NO20041840A NO20041840L (no) | 2001-10-19 | 2004-05-05 | Rosuvastatin ved predemente tilstander |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0103509A SE0103509D0 (sv) | 2001-10-19 | 2001-10-19 | Rosuvastatin in pre demented states |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE0103509D0 true SE0103509D0 (sv) | 2001-10-19 |
Family
ID=20285721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0103509A SE0103509D0 (sv) | 2001-10-19 | 2001-10-19 | Rosuvastatin in pre demented states |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20060229321A1 (https=) |
| EP (1) | EP1446123A1 (https=) |
| JP (1) | JP2005505605A (https=) |
| KR (1) | KR20040058201A (https=) |
| CN (1) | CN1604780A (https=) |
| AR (1) | AR036891A1 (https=) |
| BR (1) | BR0213434A (https=) |
| CA (1) | CA2463597A1 (https=) |
| CO (1) | CO5580773A2 (https=) |
| HU (1) | HUP0401798A3 (https=) |
| IL (1) | IL161380A0 (https=) |
| IS (1) | IS7218A (https=) |
| MX (1) | MXPA04003631A (https=) |
| NO (1) | NO20041840L (https=) |
| PL (1) | PL369573A1 (https=) |
| RU (1) | RU2004112422A (https=) |
| SE (1) | SE0103509D0 (https=) |
| WO (1) | WO2003032995A1 (https=) |
| ZA (1) | ZA200402844B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2537271A1 (en) | 2003-08-28 | 2005-03-17 | Teva Pharmaceutical Industries, Ltd. | Process for preparation of rosuvastatin calcium |
| GB0322552D0 (en) | 2003-09-26 | 2003-10-29 | Astrazeneca Uk Ltd | Therapeutic treatment |
| CA2546701C (en) | 2003-11-24 | 2010-07-27 | Teva Pharmaceutical Industries Ltd. | Crystalline ammonium salts of rosuvastatin |
| CN1894221B (zh) | 2003-12-02 | 2012-08-08 | 特瓦制药工业有限公司 | 用于表征罗苏伐他汀的参照标准品 |
| JP2007508379A (ja) | 2004-07-13 | 2007-04-05 | テバ ファーマシューティカル インダストリーズ リミティド | Ｔｅｍｐｏ媒介型酸化段階を包含するロスバスタチンの調製方法 |
| US7612203B2 (en) | 2005-02-22 | 2009-11-03 | Teva Pharmaceutical Industries Ltd. | Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof |
| KR20070062996A (ko) | 2005-08-16 | 2007-06-18 | 테바 파마슈티컬 인더스트리즈 리미티드 | 결정성 로수바스타틴 중간체 |
| WO2012073256A1 (en) | 2010-11-29 | 2012-06-07 | Cadila Healthcare Limited | Salts of rosuvastatin |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2648897B2 (ja) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
| US7189703B2 (en) * | 1998-01-09 | 2007-03-13 | Intracell, Llc | Treatment and diagnosis of alzheimer's disease |
| AR022462A1 (es) * | 1999-02-06 | 2002-09-04 | Astrazeneca Uk Ltd | Uso de un agente que disminuye el colesterol |
| US20030100493A1 (en) * | 2001-07-19 | 2003-05-29 | Sol Weiss | Sublingual use of inhibitors in the biosynthesis of cholesterol |
-
2001
- 2001-10-19 SE SE0103509A patent/SE0103509D0/xx unknown
-
2002
- 2002-10-17 AR ARP020103895A patent/AR036891A1/es not_active Application Discontinuation
- 2002-10-18 MX MXPA04003631A patent/MXPA04003631A/es not_active Application Discontinuation
- 2002-10-18 BR BR0213434-9A patent/BR0213434A/pt not_active Application Discontinuation
- 2002-10-18 EP EP02783893A patent/EP1446123A1/en not_active Withdrawn
- 2002-10-18 US US10/492,971 patent/US20060229321A1/en not_active Abandoned
- 2002-10-18 CN CNA028253477A patent/CN1604780A/zh active Pending
- 2002-10-18 PL PL02369573A patent/PL369573A1/xx not_active Application Discontinuation
- 2002-10-18 IL IL16138002A patent/IL161380A0/xx unknown
- 2002-10-18 WO PCT/SE2002/001911 patent/WO2003032995A1/en not_active Ceased
- 2002-10-18 RU RU2004112422/14A patent/RU2004112422A/ru not_active Application Discontinuation
- 2002-10-18 JP JP2003535798A patent/JP2005505605A/ja active Pending
- 2002-10-18 HU HU0401798A patent/HUP0401798A3/hu unknown
- 2002-10-18 CA CA002463597A patent/CA2463597A1/en not_active Abandoned
- 2002-10-18 KR KR10-2004-7005585A patent/KR20040058201A/ko not_active Withdrawn
-
2004
- 2004-04-13 IS IS7218A patent/IS7218A/is unknown
- 2004-04-15 ZA ZA200402844A patent/ZA200402844B/en unknown
- 2004-04-19 CO CO04035705A patent/CO5580773A2/es not_active Application Discontinuation
- 2004-05-05 NO NO20041840A patent/NO20041840L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2004112422A (ru) | 2005-04-10 |
| US20060229321A1 (en) | 2006-10-12 |
| HUP0401798A2 (hu) | 2005-01-28 |
| BR0213434A (pt) | 2004-11-09 |
| IS7218A (is) | 2004-04-13 |
| CA2463597A1 (en) | 2003-04-24 |
| WO2003032995A1 (en) | 2003-04-24 |
| ZA200402844B (en) | 2005-01-24 |
| AR036891A1 (es) | 2004-10-13 |
| PL369573A1 (en) | 2005-05-02 |
| KR20040058201A (ko) | 2004-07-03 |
| CO5580773A2 (es) | 2005-11-30 |
| MXPA04003631A (es) | 2004-07-30 |
| CN1604780A (zh) | 2005-04-06 |
| EP1446123A1 (en) | 2004-08-18 |
| JP2005505605A (ja) | 2005-02-24 |
| IL161380A0 (en) | 2004-09-27 |
| NO20041840L (no) | 2004-05-05 |
| HUP0401798A3 (en) | 2005-06-28 |
| WO2003032995A8 (en) | 2004-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE350375T1 (de) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen- abhängigen erkrankungen | |
| DK1223980T3 (da) | Anvendelse af CSF-1-inhibitorer | |
| ATE472325T1 (de) | Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen | |
| DE60124684D1 (de) | Sulfonamido-substituierte verbrückte bicycloalkylderivative | |
| EP1622633A4 (en) | Treatment of t-cell mediated diseases | |
| DE60317198D1 (de) | Proteinkinaseinhibitoren | |
| DE60331187D1 (de) | Kinaseinhibitoren | |
| RU2005108133A (ru) | Дипептиднитрильные ингибиторы катепсина к | |
| BR0111913A (pt) | Análogos de gabapentina para distúrbios do sono | |
| DE60127537D1 (de) | VERWENDUNG VON 2-(4-ETHOXY-PHENYL)-3-(4-METHANESULFONYL-PHENYL)-PYRAZOLOÄ1,5-bÜPYRIDAZINE ZUR BEHANDLUNG VON NICHTULZERATIVER DYSPEPSIE | |
| DE50201780D1 (de) | Halogensubstituierte aminodicarbonsäurederivate als arzneimittel zur behandlung von herz-kreislauf-erkrankungen | |
| DE60139466D1 (de) | Behandlung von diabetes | |
| GB0130677D0 (en) | Medicaments and novel compounds | |
| SE0103509D0 (sv) | Rosuvastatin in pre demented states | |
| NO20051893L (no) | Ny forbindelse | |
| ATE469886T1 (de) | 17beta-hydroxysteroid dehydrogenase typ-3 hemmer zur behandlung von androgen abhängigen erkrankungen | |
| TNSN06138A1 (fr) | Inhibitors of the mutant form of kit | |
| ATE357912T1 (de) | Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten | |
| ATE289196T1 (de) | Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen | |
| DK0583271T3 (da) | Arylmorpholin, fremstilling og anvendelse | |
| CY1106155T1 (el) | Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους | |
| FR2848817B1 (fr) | Matelas therapeutique tricouches pour patients obeses | |
| DE60200160D1 (de) | Verwendung von Cilobradine oder pharmazeutisch akzeptablen Salze zur Behandlung oder Prävention von Herzversagen | |
| JP2005505605A5 (https=) | ||
| DE60315666D1 (de) | Furopyridin- und furopyrimidinderivate zur behandlung von hyperproliferativen erkrankungen |